THE EFFECTS OF PEG-INTERLEUKIN-2 AND INTERLEUKIN-2 ON ESSENTIAL-HYPERTENSION AND CELLULAR IMMUNE FUNCTION IN THE SPONTANEOUSLY HYPERTENSIVE RAT

被引:2
|
作者
OFOSUAPPIAH, W [1 ]
RUGGIERO, C [1 ]
DZIELAK, DJ [1 ]
ANTZELEVITCH, C [1 ]
机构
[1] UNIV MISSISSIPPI,MED CTR,DEPT SURG,JACKSON,MS 39216
关键词
INTERLEUKIN-2; HYPERTENSION; CELLULAR IMMUNITY;
D O I
10.3109/10641969309032945
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of recombinant human interleukin-2 covalently linked to polyethylene glycol (PEG-IL-2) or interleukin-2 (IL-2) on hypertension and in vitro suppressor T cell function in the spontaneously hypertensive rats (SHR) were investigated. Male young prehypertensive (4 weeks old) SHRs and adult (10 weeks old) SHRs with established hypertension were injected with low (5,000 units (u)/kg) or high (50,000-100,000 u/kg)dose of PEG-IL-2 or IL-2 as a single bolus or repeated injections. Systolic blood pressure was measured twice weekly using the tail-cuff technique. Systolic blood pressure in the PEG-IL-2 or IL-2 treated animals, irrespective of age, dose, or route of injection, did not differ significantly from that measured in vehicle-treated controls over a 10 week period. Mean arterial pressure measured by intra-arterial catheter was 159 +/- 7 mm Hg 10 weeks after treatment with repeated injections of 5,000 u/kg of PEG-IL-2 and 158 +/- 9 mm Hg in vehicle-treated controls. All rats injected with IL-2 had IL-2-specific IgG antibody in their sera. None of the PEG-IL-2 treated rats had any detectable anti-IL-2 antibodies in their sera. Thus, PEG-IL-2 showed far less immunogenicity than IL-2. Suppressor T (Ts) cells generated from adult SHR spleen cells failed to suppress pokeweed mitogen (PWM)-driven immunoglobulin G (IgG) synthesis. PEG-IL-2 or IL-2 supplementation both in vitro and in vivo restored the ability of adult SHR to generate Ts cells able to inhibit IgG synthesis. Our data suggest that PEG-IL-2 or IL-2 administration does correct a prominent defective Ts cell activity found in adult SHR, but that correction of this immune abnormality is not attended by an attenuation of hypertension.
引用
收藏
页码:435 / 457
页数:23
相关论文
共 50 条
  • [31] Effects of aprotinin on serum interleukin-2 and soluble interleukin-2 receptor during cardiopulmonary bypass
    Luo Jun
    Wang Dongfang
    Lan Hongjun
    Sun Zongquan
    Current Medical Science, 2000, 20 (2) : 143 - 144
  • [32] LOCALIZATION OF INTERLEUKIN-2 IMMUNOREACTIVITY AND INTERLEUKIN-2 RECEPTORS IN THE RAT-BRAIN - INTERACTION WITH THE CHOLINERGIC SYSTEM
    ARAUJO, DM
    LAPCHAK, PA
    COLLIER, B
    QUIRION, R
    BRAIN RESEARCH, 1989, 498 (02) : 257 - 266
  • [33] Effects of Aprotinin on Serum Interleukin-2 and Soluble Interleukin-2 Receptor during Cardiopulmonary Bypass
    罗军
    汪东仿
    蓝鸿钧
    孙宗全
    Journal of Tongji Medical University, 2000, (02) : 143 - 144
  • [34] EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-2-ACTIVATED CELLS ON INVITRO MYELOPOIESIS
    CLERIGUE, M
    PISA, P
    TSAI, L
    HANSON, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 81 (03): : 459 - 465
  • [35] INTERLEUKIN-2 DOES NOT ACUTELY EFFECT RENAL-FUNCTION IN THE RAT
    TOLINS, JP
    RAIJ, L
    CLINICAL RESEARCH, 1987, 35 (03): : A558 - A558
  • [36] RENAL EFFECTS OF INTERLEUKIN-2 THERAPY
    WEBB, D
    BELLDEGRUN, A
    AUSTIN, H
    LINEHAN, W
    VAUGHAN, E
    ROSENBERG, S
    KIDNEY INTERNATIONAL, 1987, 31 (01) : 224 - 224
  • [37] THE INVIVO EFFECTS OF INTERLEUKIN-2 (TCGF)
    WAGNER, H
    HARDT, C
    HEEG, K
    PFIZENMAIER, K
    STOTTER, H
    ROLLINGHOFF, M
    IMMUNOBIOLOGY, 1982, 161 (1-2) : 139 - 156
  • [38] Effects of interleukin-2 in immunostimulation and immunosuppression
    Pol, Jonathan G.
    Caudana, Pamela
    Paillet, Juliette
    Piaggio, Eliane
    Kroemer, Guido
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (01):
  • [39] CARDIORESPIRATORY EFFECTS OF IMMUNOTHERAPY WITH INTERLEUKIN-2
    LEE, RE
    LOTZE, MT
    SKIBBER, JM
    TUCKER, E
    BONOW, RO
    OGNIBENE, FP
    CARRASQUILLO, JA
    SHELHAMER, JH
    PARRILLO, JE
    ROSENBERG, SA
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 7 - 20
  • [40] EFFECTS OF INTERLEUKIN-2 ON MYELODYSPLASTIC SYNDROMES
    OGATA, K
    YOKOSE, N
    ITO, T
    AN, E
    DAN, K
    NOMURA, T
    LEUKEMIA RESEARCH, 1993, 17 (02) : 137 - 142